Andy Quach

Andy Quach is currently serving as the Senior Manager of External Manufacturing at Prime Medicine, Inc. since February 2023, focusing on Cell and Gene Therapy Supply Chain and External Manufacturing. Prior to this role, Quach gained extensive experience at Q32 Bio Inc. as Scientist II and Scientist I in Process Development, leading a CMC program and overseeing the clinical manufacturing of protein-based therapeutics. Quach's background also includes work as a Process Development Engineer II at Surface Oncology, where responsibilities encompassed upstream and cell line process development, as well as the startup of a new lab. Previous roles include Associate Process Engineer in Biologics Process Development at Momenta Pharmaceuticals, Bioprocess Engineer I at Joule Unlimited Technologies, and undergraduate research positions at Syracuse University and Tufts University. Quach holds a Master’s Degree in Biotechnology from Northeastern University and a Bachelor of Science in Bioengineering/Biomedical Engineering from Syracuse University.